Literature DB >> 9796631

Association between coronary heart disease and cancers of the breast, prostate, and colon.

A I Neugut1, D J Rosenberg, H Ahsan, J S Jacobson, N Wahid, M Hagan, M I Rahman, Z R Khan, L Chen, A Pablos-Mendez, S Shea.   

Abstract

Coronary heart disease (CHD) and cancers of the breast, prostate, and colon are more common in industrialized countries than in the developing world, and to some degree, these conditions appear to share risk factors. To investigate whether there is an association between these cancers and a prior history of CHD, a hospital-based case-control study was conducted at Columbia-Presbyterian Medical Center in New York. The study was based on 252 breast cancer cases, 256 colorectal cancer cases, and 322 benign surgical controls, all of whom underwent biopsy or surgery between January 1989 and December 1992, and on 319 prostate cancer cases and 189 benign prostatic hypertrophy controls diagnosed between January 1984 and December 1986 (prior to widespread use of prostate-specific antigen screening). Medical records were reviewed on each, focusing on the preoperative anesthesia and surgical clearances. No association was found between a history of CHD and breast or colorectal cancer, but an elevated risk was found for prostate cancer (odds ratio, 2.00; 95% confidence interval, 1.18-3.39), using unconditional logistic regression with adjustment for appropriate confounders. No association was found between cigarette smoking and any of the three cancers. Aspirin use was protective for colorectal cancer (odds ratio, 0.35; 95% confidence interval, 0.17-0.73) but had no association with breast or prostate cancer. The study suggests that individuals with CHD are at elevated risk for prostate cancer but not breast or colorectal cancer. Etiological risk factors associated with CHD should be investigated with regard to prostate cancer. Patients with CHD may represent a high-risk group for prostate cancer and potential future targets for prostate cancer screening interventions.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9796631

Source DB:  PubMed          Journal:  Cancer Epidemiol Biomarkers Prev        ISSN: 1055-9965            Impact factor:   4.254


  29 in total

1.  Aspirin use and the risk of prostate cancer: a meta-analysis of 24 epidemiologic studies.

Authors:  Tian-Bao Huang; Yang Yan; Zhui-Feng Guo; Xiao-Long Zhang; Huan Liu; Jiang Geng; Xu-Dong Yao; Jun-Hua Zheng
Journal:  Int Urol Nephrol       Date:  2014-04-01       Impact factor: 2.370

2.  Chronic Inflammation in Prostate Biopsy Cores is an Independent Factor that Lowers the Risk of Prostate Cancer Detection and is Inversely Associated with the Number of Positive Cores in Patients Elected to a First Biopsy.

Authors:  Antonio B Porcaro; Giovanni Novella; Daniele Mattevi; Leonardo Bizzotto; Giovanni Cacciamani; Nicolò De Luyk; Irene Tamanini; Maria A Cerruto; Matteo Brunelli; Walter Artibani
Journal:  Curr Urol       Date:  2016-05-20

Review 3.  Aspirin and urologic cancer risk: an update.

Authors:  Cristina Bosetti; Valentina Rosato; Silvano Gallus; Carlo La Vecchia
Journal:  Nat Rev Urol       Date:  2012-01-24       Impact factor: 14.432

4.  Use of aspirin and other nonsteroidal antiinflammatory medications in relation to prostate cancer risk.

Authors:  Claudia A Salinas; Erika M Kwon; Liesel M FitzGerald; Ziding Feng; Peter S Nelson; Elaine A Ostrander; Ulrike Peters; Janet L Stanford
Journal:  Am J Epidemiol       Date:  2010-08-05       Impact factor: 4.897

5.  Vascular damage induced by type 2 diabetes mellitus as a risk factor for benign prostatic hyperplasia.

Authors:  A P Berger; M Deibl; E J Halpern; M Lechleitner; J Bektic; W Horninger; G Fritsche; H Steiner; A Pelzer; G Bartsch; F Frauscher
Journal:  Diabetologia       Date:  2005-03-09       Impact factor: 10.122

6.  Prescriptions for selective cyclooxygenase-2 inhibitors, non-selective non-steroidal anti-inflammatory drugs, and risk of breast cancer in a population-based case-control study.

Authors:  Deirdre P Cronin-Fenton; Lars Pedersen; Timothy L Lash; Søren Friis; John A Baron; Henrik T Sørensen
Journal:  Breast Cancer Res       Date:  2010-03-01       Impact factor: 6.466

7.  Nonsteroidal anti-inflammatory drugs and prostate cancer: a systematic review of the literature and meta-analysis.

Authors:  Siavash Jafari; Mahyar Etminan; Kourosh Afshar
Journal:  Can Urol Assoc J       Date:  2009-08       Impact factor: 1.862

Review 8.  Cyclooxygenase-2 and the inflammogenesis of breast cancer.

Authors:  Randall E Harris; Bruce C Casto; Zachary M Harris
Journal:  World J Clin Oncol       Date:  2014-10-10

9.  Association Between Colorectal Cancer and Atherosclerotic Diseases: A Study Using a National Inpatient Database in Japan.

Authors:  Yutaka Yamaji; Hideo Yasunaga; Yoshihiro Hirata; Atsuo Yamada; Shuntaro Yoshida; Hiromasa Horiguchi; Kiyohide Fushimi; Kazuhiko Koike
Journal:  Dig Dis Sci       Date:  2016-02-01       Impact factor: 3.199

10.  Nested case-control study on the risk factors of colorectal cancer.

Authors:  Kun Chen; Jian Cai; Xi-Yong Liu; Xi-Yuan Ma; Kai-Yan Yao; Shu Zheng
Journal:  World J Gastroenterol       Date:  2003-01       Impact factor: 5.742

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.